A surrogate endpoint is a biomarker or clinical measure used as a substitute for a true endpoint that directly measures clinical benefit, such as overall survival or quality of life. It is often used in clinical trials to predict the effect of a treatment more quickly or easily than waiting for the true endpoint to occur, but it must be validated to ensure it accurately reflects the desired clinical outcome.